JP2019534709A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019534709A5 JP2019534709A5 JP2019537752A JP2019537752A JP2019534709A5 JP 2019534709 A5 JP2019534709 A5 JP 2019534709A5 JP 2019537752 A JP2019537752 A JP 2019537752A JP 2019537752 A JP2019537752 A JP 2019537752A JP 2019534709 A5 JP2019534709 A5 JP 2019534709A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated polynucleotide
- polynucleotide molecule
- rsv
- protein
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022144109A JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A JP7862507B2 (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662399133P | 2016-09-23 | 2016-09-23 | |
| US62/399,133 | 2016-09-23 | ||
| US201662400476P | 2016-09-27 | 2016-09-27 | |
| US62/400,476 | 2016-09-27 | ||
| PCT/US2017/053047 WO2018057950A1 (en) | 2016-09-23 | 2017-09-22 | Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144109A Division JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019534709A JP2019534709A (ja) | 2019-12-05 |
| JP2019534709A5 true JP2019534709A5 (enExample) | 2020-10-08 |
| JP7198759B2 JP7198759B2 (ja) | 2023-01-04 |
Family
ID=60009756
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537752A Active JP7198759B2 (ja) | 2016-09-23 | 2017-09-22 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2022144109A Active JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A Active JP7862507B2 (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022144109A Active JP7573001B2 (ja) | 2016-09-23 | 2022-09-09 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
| JP2024178707A Active JP7862507B2 (ja) | 2016-09-23 | 2024-10-11 | 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補 |
Country Status (5)
| Country | Link |
|---|---|
| US (4) | US10808012B2 (enExample) |
| EP (1) | EP3515930A1 (enExample) |
| JP (3) | JP7198759B2 (enExample) |
| AU (5) | AU2017332789B2 (enExample) |
| WO (1) | WO2018057950A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2900713A1 (en) | 2013-02-08 | 2014-08-14 | Steffen Mueller | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
| AU2017332789B2 (en) | 2016-09-23 | 2021-05-27 | Codagenix, Inc. | Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes |
| JP2021508696A (ja) | 2017-12-22 | 2021-03-11 | コーダ−ジェニックス・インコーポレイテッドＣｏｄａ−Ｇｅｎｉｘ， Ｉｎｃ． | がん処置のためのコドン対脱最適化領域を有する組換え型ウイルス及びその使用法 |
| WO2019172982A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| WO2021231767A1 (en) | 2020-05-13 | 2021-11-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rsv vaccine bearing one or more p gene mutations |
| WO2022011428A1 (en) * | 2020-07-16 | 2022-01-20 | Griffith University | Live-attenuated virus vaccine |
| AU2022254738A1 (en) * | 2021-04-08 | 2023-09-07 | Codagenix Inc. | Method of eliciting an immune response against respiratory syncytial virus |
| WO2025054424A1 (en) * | 2023-09-06 | 2025-03-13 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Human parainfluenza virus immunogenic molecules |
| WO2025128971A1 (en) * | 2023-12-14 | 2025-06-19 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Rsv vaccine bearing a polynucleotide which is de-optimised and de-attenuated |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3224404A1 (de) | 1982-06-30 | 1984-01-05 | LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl | Reibungskupplung sowie verfahren zu deren montage |
| US6264957B1 (en) | 1995-09-27 | 2001-07-24 | The United States Of America As Represented By The Department Of Health And Human Services | Product of infectious respiratory syncytial virus from cloned nucleotide sequences |
| EP0912724B1 (en) | 1996-07-15 | 2009-12-09 | The Government of The United States of America, as represented by The Department of Health and Human Services | Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| DE69842165D1 (de) | 1997-05-23 | 2011-04-21 | Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services | Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen |
| JP2002541785A (ja) | 1999-04-13 | 2002-12-10 | アメリカ合衆国 | クローン化ヌクレオチド配列からの弱毒化キメラ呼吸系発疹ウイルスワクチンの製造 |
| US20040161846A1 (en) | 2000-11-22 | 2004-08-19 | Mason Anthony John | Method of expression and agents identified thereby |
| WO2006085987A2 (en) | 2004-07-09 | 2006-08-17 | University Of Iowa Research Foundation | Rna interference in respiratory epitheial cells |
| EP2808384B1 (en) | 2004-10-08 | 2017-12-06 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Modulation of replicative fitness by using less frequently used synonymous codons |
| PL2139515T5 (pl) | 2007-03-30 | 2024-04-08 | The Research Foundation Of The State University Of New York | Atenuowane wirusy przydatne w szczepionkach |
| BRPI0921424A2 (pt) | 2008-11-05 | 2016-01-05 | Merck Sharp & Dohme | vírus sincicial respiratório atenuado, composição imunogênica, molécula de ácido nucléico, célula recombinante, método para produzir uma resposta imune protetiva em um paciente, e, uso de uma quantidade imunologicamente eficaz de um ou mais dos seguintes: um rsv atenuado, uma população de rsv atenuado e uma composição imunogênica. |
| US10227569B2 (en) | 2011-04-12 | 2019-03-12 | Emory University | Respiratory syncytial virus expression vectors |
| CA2900713A1 (en) | 2013-02-08 | 2014-08-14 | Steffen Mueller | Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization |
| AU2017332789B2 (en) | 2016-09-23 | 2021-05-27 | Codagenix, Inc. | Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes |
-
2017
- 2017-09-22 AU AU2017332789A patent/AU2017332789B2/en active Active
- 2017-09-22 EP EP17778443.6A patent/EP3515930A1/en active Pending
- 2017-09-22 US US16/335,099 patent/US10808012B2/en active Active
- 2017-09-22 JP JP2019537752A patent/JP7198759B2/ja active Active
- 2017-09-22 WO PCT/US2017/053047 patent/WO2018057950A1/en not_active Ceased
-
2020
- 2020-08-31 US US17/008,025 patent/US11390651B2/en active Active
-
2021
- 2021-08-19 AU AU2021218112A patent/AU2021218112B2/en active Active
-
2022
- 2022-06-28 US US17/851,905 patent/US12054519B2/en active Active
- 2022-09-09 JP JP2022144109A patent/JP7573001B2/ja active Active
- 2022-10-21 AU AU2022256195A patent/AU2022256195B2/en active Active
-
2024
- 2024-06-11 AU AU2024203948A patent/AU2024203948B2/en active Active
- 2024-06-28 US US18/758,660 patent/US20240417431A1/en active Pending
- 2024-10-11 JP JP2024178707A patent/JP7862507B2/ja active Active
-
2026
- 2026-05-05 AU AU2026203425A patent/AU2026203425A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276210B2 (en) | Mers-cov vaccine | |
| MX2020002876A (es) | Metodo para la induccion segura de inmunidad contra el vsr. | |
| RU2016146801A (ru) | Вакцинная композиция против инфекции, вызванной streptococcus suis | |
| JP2016539946A5 (enExample) | ||
| JP2018504412A5 (enExample) | ||
| JP2012115277A5 (enExample) | ||
| HRP20230694T1 (hr) | Smanjenje ljudskog respiratornog sincicijskog virusa prema ljestvici genoma deoptimizacijom kodon-para | |
| WO2014205579A4 (en) | Modified matrix proteins of vesicular stomatitis virus | |
| JP2010508030A5 (enExample) | ||
| JP2016520530A5 (enExample) | ||
| JP2019500320A5 (enExample) | ||
| EP2552490A4 (en) | INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF | |
| JP2014527526A5 (enExample) | ||
| FI3511015T9 (fi) | Geneettisesti stabiili elävä heikennetty respiratory syncytial -virusrokote ja sen tuottaminen | |
| JP2020515283A5 (enExample) | ||
| CN107344969B (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| RU2018112060A (ru) | Слитый белок | |
| JP2015525794A5 (enExample) | ||
| JP2012517239A5 (enExample) | ||
| EP4251200B1 (en) | Novel replication deficient influenza a virus inducing high levels of type i interferon | |
| JP2019534242A5 (enExample) | ||
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| JP2018536428A5 (enExample) | ||
| JP2020522249A5 (enExample) | ||
| JP6373601B2 (ja) | アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド |